Inner Mongolia Furui Med Sci (300049) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.06 Million ≈ $20.35 Million USD) by net assets (CN¥2.79 Billion ≈ $407.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300049 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Inner Mongolia Furui Med Sci - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Inner Mongolia Furui Med Sci's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Inner Mongolia Furui Med Sci Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Realia
MC:RLIA
|
0.038x |
|
Kepco Plant S&
KO:051600
|
0.008x |
|
Jiangsu Guomao Reducer Co Ltd
SHG:603915
|
0.015x |
|
IGNITIS GRUPE SP.GDR/1
F:IGV
|
0.048x |
|
Taiji Computer Corp Ltd
SHE:002368
|
0.046x |
|
Galapagos N.V.
AS:GLPG
|
-0.024x |
|
Renew Energy Global PLC
NASDAQ:RNW
|
-0.012x |
|
China Railway Construction Corporation Limited
F:4FF
|
0.045x |
Annual Cash Flow Conversion Efficiency for Inner Mongolia Furui Med Sci (2006–2025)
The table below shows the annual cash flow conversion efficiency of Inner Mongolia Furui Med Sci from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Inner Mongolia Furui Med Sci.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.79 Billion ≈ $407.78 Million |
CN¥354.15 Million ≈ $51.82 Million |
0.127x | +22.14% |
| 2024-12-31 | CN¥2.13 Billion ≈ $311.38 Million |
CN¥221.41 Million ≈ $32.40 Million |
0.104x | -36.95% |
| 2023-12-31 | CN¥1.85 Billion ≈ $270.33 Million |
CN¥304.89 Million ≈ $44.61 Million |
0.165x | +59.05% |
| 2022-12-31 | CN¥1.83 Billion ≈ $267.18 Million |
CN¥189.46 Million ≈ $27.72 Million |
0.104x | -15.81% |
| 2021-12-31 | CN¥1.81 Billion ≈ $264.23 Million |
CN¥222.55 Million ≈ $32.57 Million |
0.123x | -0.52% |
| 2020-12-31 | CN¥1.62 Billion ≈ $236.40 Million |
CN¥200.15 Million ≈ $29.29 Million |
0.124x | -24.98% |
| 2019-12-31 | CN¥1.55 Billion ≈ $227.04 Million |
CN¥256.23 Million ≈ $37.49 Million |
0.165x | +219.10% |
| 2018-12-31 | CN¥1.51 Billion ≈ $221.53 Million |
CN¥78.35 Million ≈ $11.46 Million |
0.052x | -24.72% |
| 2017-12-31 | CN¥1.92 Billion ≈ $280.39 Million |
CN¥131.72 Million ≈ $19.27 Million |
0.069x | -15.69% |
| 2016-12-31 | CN¥1.83 Billion ≈ $267.13 Million |
CN¥148.84 Million ≈ $21.78 Million |
0.082x | -14.91% |
| 2015-12-31 | CN¥1.65 Billion ≈ $241.53 Million |
CN¥158.16 Million ≈ $23.14 Million |
0.096x | +72.35% |
| 2014-12-31 | CN¥915.10 Million ≈ $133.91 Million |
CN¥50.88 Million ≈ $7.44 Million |
0.056x | +47.66% |
| 2013-12-31 | CN¥748.53 Million ≈ $109.53 Million |
CN¥28.18 Million ≈ $4.12 Million |
0.038x | -67.84% |
| 2012-12-31 | CN¥733.64 Million ≈ $107.35 Million |
CN¥85.88 Million ≈ $12.57 Million |
0.117x | +8.65% |
| 2011-12-31 | CN¥703.08 Million ≈ $102.88 Million |
CN¥75.75 Million ≈ $11.08 Million |
0.108x | +50.54% |
| 2010-12-31 | CN¥687.42 Million ≈ $100.59 Million |
CN¥49.20 Million ≈ $7.20 Million |
0.072x | +637.68% |
| 2009-12-31 | CN¥157.46 Million ≈ $23.04 Million |
CN¥-2.10 Million ≈ $-306.69K |
-0.013x | -105.09% |
| 2008-12-31 | CN¥139.52 Million ≈ $20.42 Million |
CN¥36.47 Million ≈ $5.34 Million |
0.261x | +87.15% |
| 2007-12-31 | CN¥127.76 Million ≈ $18.70 Million |
CN¥17.85 Million ≈ $2.61 Million |
0.140x | -64.88% |
| 2006-12-31 | CN¥124.50 Million ≈ $18.22 Million |
CN¥49.52 Million ≈ $7.25 Million |
0.398x | -- |
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liv… Read more